Table:
begin	end	state
1	42	cytoplasmic
43	62	transmembrane
63	67	non-cytoplasmic
68	88	transmembrane
89	113	cytoplasmic
114	139	transmembrane
140	150	non-cytoplasmic
151	170	transmembrane
171	177	cytoplasmic
178	200	transmembrane
201	219	non-cytoplasmic
220	245	transmembrane
246	265	cytoplasmic
266	289	transmembrane
290	308	non-cytoplasmic
309	331	transmembrane
332	356	cytoplasmic
357	380	transmembrane
381	385	non-cytoplasmic
386	407	transmembrane
408	428	cytoplasmic
429	448	transmembrane
449	453	non-cytoplasmic
454	472	transmembrane
473	494	cytoplasmic

Input:
>AO353_24335 FitnessBrowser__pseudo3_N2E3:AO353_24335
MKKQKIQSLSAVQCGSELKDRSNWLDSHESGYSKHLKKRHVQMMALGGAIGTGLFLGAGA
RLQIAGPALAVIYLVCGIFAFFILRALGELVMHRPSSGSFVSYTREFMGERASFVAGWMY
FVVWALTGVVDITAIAIYMKYWSVFSDVPQWVFALSALGVVTLMNMVGVKWFGEMEFWFA
VIKVAAISIFLVIGSFFFATGHEVAGHIPGLHLITDNGGIFPHGLLPAIIIVQGVIFAYA
SIELVGTAAGETADARKVIPKAINGVIWRISLFYVGSVFLLVTVLPWTAYSANVSPFVTF
FEALGVPGIGSVMNIVVMTAALSSLNSGLYATGRVLRSLAMGGSAPKMFKRMSSQGVPYM
GILVTMGINVFGVVLNFLIPAQLFELLLNLVSLGIISTWAFIVLSQINYRRAVKRGEVEM
VSFRMPGAPFTSWLTLVFLLVVLVLLAFDYPNGTYTVLSIPLVAGALMLGWSKAVRSKAK
GSEEIKSDPSHVGA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server